Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.
Clinical trial NCT07136974 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07136974
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2028-08-30
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.